[1] Ferrer-Batallé M, Ramirez M, Llop E et al. Comparative study of blood-based biomarkers, α2,3-sialic acid PSA and PHI, for high-risk prostate cancer detection [J]. Int J Mol Sci, 2017, 18(4): pii E845.
[2] Cui H, Lin Y, Zhao X, et al. Differential expression of the α2,3-sialic acid residues in breast cancer is associated with metastatic potential [J]. Oncol Rep, 2011, 25(5):1365-1371.
[3] Wang M, Cui HX, Liu JCh, et al. Effect of lupeol on migration and invasion of human breast cancer MDA-MB-231 cells and its mechanism[J]. Acta Pharmaceutica Sinica, 2016, 51 (4): 558-562. (in Chinese)
王明,崔红霞,刘吉成,等.羽扇豆醇对人乳腺癌 MDA-MB-231 细胞侵袭转移作用及机制研究[J].药学学报,2016, 51 (4): 558-562.
[4] Weber WA, Czernin J, Phelps ME, et al. Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs[J]. Nat Clini Pract Oncol, 2008,5(1):44-54.
[5] Monk BJ, Huang HQ, Burger RA, et al. Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study[J]. Gynecol Cncol, 2013,128(3):573-578.
[6] Smolle E, Taucher Ⅴ, Pichler M, et al. Targeting signaling pathways in epithelial ovarian cancer[J]. Int J Mol Sci,2013,14(5):9536-9555.
[7] Kassab AE, Gedawy EM. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase Ⅱ inhibition, and antibacterial activity[J]. Eur J Med Chem, 2018,150(4):403-418.
[8] Emens LA, Silverstein SC, Khleif S, et al. Toward integrative cancer immunotherapy: targeting the tumor microenvironment[J]. J Transl Med,2012,10:10.
[9] Cui HX, Wang HL, Wang YCh, et al. Silencing ST3GalⅢ Inhibits Adhesion and Invasion of MDA-B-31 Cells[J]. Chinese Journal of Biochemistry and Molecular Biology,2016,32(6): 692-98. (in Chinese)
崔红霞,王宏兰,王玉春,等. 沉默 ST3GalⅢ 抑制 MDA-MB-31 细胞黏附和侵袭能力[J].中国生物化学与分子生物学报,2016,32(6): 692-98.
[10] Lee WJ, Wu LF, Chen WK, et al. Inhibitory effect of luteolin on hepatocyte growth factor/scatterfactor-nduced HepG2 cell invasion involving both MAPK/ERKs and PI3K-kt pathways[J]. Chem Biol Interact, 2006,160(2):123-33.
[11] Gong L, Li Y, Nedeljkovic-urepa A, et al. Inactivation of NF-appaB by genistein is mediated via Akt signaling pathway in breast cancer cells[J]. Oncogene, 2003,22(30):4702-709.
[12] Kim D, Kim S, Koh H, et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production[J]. FASEB J,2001,15(11):1953-962.
|